Valuation : Divi's Laboratories Limited

Market Cap 2,433B 25.64B 22.11B 20.8B 18.95B 35.64B 35.83B 246B 95.71B 1,238B 96.25B 94.16B 4,104B P/E 2027 *
74.6x
P/E 2028 * 61.9x
Enterprise Value 2,398B 25.27B 21.8B 20.5B 18.68B 35.12B 35.31B 242B 94.34B 1,220B 94.87B 92.81B 4,045B EV / Sales 2027 *
19.1x
EV / Sales 2028 * 15.9x
Free-Float
48.01%
Yield 2027 *
0.39%
Yield 2028 * 0.42%
1 day-0.45%
1 week+1.10%
Current month-3.62%
1 month+6.28%
3 months+39.66%
6 months+42.48%
Current year+42.73%
1 week 9,035
Extreme 9035
9,467
1 month 8,105
Extreme 8105
9,467
Current year 5,647.5
Extreme 5647.5
9,467
1 year 5,636.5
Extreme 5636.5
9,467
3 years 3,295.3
Extreme 3295.3
9,467
5 years 2,730
Extreme 2730
9,467
10 years 532.65
Extreme 532.65
9,467
Manager TitleAgeSince
Chief Executive Officer 75 25/11/2009
Chief Executive Officer 48 03/01/2020
Director of Finance/CFO 65 31/07/2025
Director TitleAgeSince
Director/Board Member 48 25/11/2009
Chairman 75 25/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.27%+1.10%+49.07%+151.39% 25.64B
+0.28%-5.97%+58.34%+108.22% 1,034B
+2.01%-0.71%+53.07%+68.99% 654B
+1.39%-2.18%+23.57%+75.43% 459B
-1.50%-7.04%+33.55%+33.94% 343B
+6.25%+2.04%+28.97%+46.57% 307B
-0.07%-4.12%+0.95%+11.79% 251B
+1.92%-0.93%+52.28%+70.67% 237B
+0.51%-4.52%-19.50%-54.83% 202B
+2.45%+0.77%+32.71%+95.59% 186B
Average +1.41%-2.11%+31.30%+60.78% 369.72B
Weighted average by Cap. +1.62%-3.26%+38.47%+67.03%

Financials

2027 *2028 *
Net sales 126B 1.33B 1.14B 1.08B 979M 1.84B 1.85B 12.71B 4.95B 63.97B 4.97B 4.87B 212B 150B 1.58B 1.36B 1.28B 1.17B 2.2B 2.21B 15.15B 5.9B 76.25B 5.93B 5.8B 253B
Net income 32.65B 344M 297M 279M 254M 478M 481M 3.3B 1.28B 16.61B 1.29B 1.26B 55.07B 39.42B 415M 358M 337M 307M 577M 580M 3.98B 1.55B 20.05B 1.56B 1.53B 66.49B
Net Debt -35B -369M -318M -299M -273M -513M -515M -3.54B -1.38B -17.8B -1.38B -1.35B -59.03B -44.85B -473M -408M -383M -349M -657M -661M -4.53B -1.76B -22.82B -1.77B -1.74B -75.65B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
02/09/26 9,142.00 -0.25% 87,045
01/09/26 ₹9,165.00 -3.19% 485,620
31/08/26 ₹9,467.00 +2.47% 680,805
28/08/26 ₹9,239.00 +1.98% 773,225
27/08/26 ₹9,060.00 +0.39% 527,307
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
9,165.00INR
Average target price
8,447.00INR
Spread / Average Target
-7.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock